Adial Pharmaceuticals, Inc

ADILNASDAQ • USD
4.13 USD
↗ 0.12 (2.99%)AT CLOSE (03:59 PM EDT)
4.11
↘ 0.02 (0.56%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
4.11
↘ 0.02 (0.56%)
🔴Market: CLOSED

Adial Pharmaceuticals, Inc (ADIL) trades at $3.98 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (150.6%) and a bullish Golden Cross on the moving averages. On the valuation side, ADIL appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 1, 2026.

Open?$4.12
High?$4.45
Low?$3.86
Prev. Close?$4.01
Volume?13.4K
Avg. Volume?51.6K
VWAP?$4.16
Rel. Volume?0.26x
Bid / Ask
Bid?$3.02 × 100
Ask?$5.15 × 500
Spread?$2.13
Midpoint?$4.09
Valuation & Ratios
Market Cap?12.1M
Shares Out?2.6M
Float?2.4M
Float %?91.9%
P/E Ratio?N/A
P/B Ratio?-0.32
EPS?-$19.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Employees
6
Market Cap
11.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-07-27
Address
1180 SEMINOLE TRAIL
CHARLOTTESVILLE, VA 22901
Phone: 434-422-9800
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
65
Piotroski F-Score?0/9Weak
Altman Z-Score?-12.25Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?8.70%Elevated
Short Interest?210.0K
Days to Cover?4.1
Free Float2.4M
Avg Daily Volume50.9K
Settlement Date2026-09-15
Financial Health
Current Ratio?5.63Strong
Quick Ratio?5.63Strong
Cash Ratio?5.61Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-0.32CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
150.6%STRONG▾
ROA?
S&P
3
-198.7%WEAK▾
Cash Flow & Enterprise
FCF?$-11132939
Enterprise Value?$-16595802
Fundamentals ratios updated end of day